A detailed history of Intrepid Family Office LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Intrepid Family Office LLC holds 12,500 shares of SAVA stock, worth $32,375. This represents 0.33% of its overall portfolio holdings.

Number of Shares
12,500
Previous 15,000 16.67%
Holding current value
$32,375
Previous $367,000 43.32%
% of portfolio
0.33%
Previous 0.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$16.64 - $25.32 $41,600 - $63,300
-2,500 Reduced 16.67%
12,500 $208,000
Q1 2023

May 15, 2023

SELL
$23.46 - $36.44 $234,600 - $364,400
-10,000 Reduced 40.0%
15,000 $361,000
Q2 2022

Aug 15, 2022

SELL
$17.22 - $38.47 $172,200 - $384,700
-10,000 Reduced 28.57%
25,000 $703,000
Q1 2022

May 16, 2022

BUY
$32.6 - $53.05 $52,160 - $84,880
1,600 Added 4.79%
35,000 $1.3 Million
Q4 2021

Feb 14, 2022

BUY
$36.77 - $90.91 $1.23 Million - $3.04 Million
33,400 New
33,400 $1.46 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $104M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Intrepid Family Office LLC Portfolio

Follow Intrepid Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Family Office LLC with notifications on news.